Next Article in Journal
Descriptive Analysis of First-Line Non-Small Cell Lung Cancer Treatment with Pembrolizumab in Tumors Expressing PD-L1 ≥ 50% in Patients Treated in Quebec’s University Teaching Hospitals (DALP-First Study)
Previous Article in Journal
Survival Benefits of Adjuvant Chemotherapy for Positive Soft Tissue Surgical Margins Following Radical Cystectomy in Bladder Cancer with Extravesical Extension
 
 
Review

Article Versions Notes

Curr. Oncol. 2023, 30(3), 3232-3250; https://doi.org/10.3390/curroncol30030246
Action Date Notes Link
article xml file uploaded 11 March 2023 08:24 CET Original file -
article xml uploaded. 11 March 2023 08:24 CET Update -
article pdf uploaded. 11 March 2023 08:24 CET Version of Record https://www.mdpi.com/1718-7729/30/3/246/pdf-vor
article html file updated 11 March 2023 08:25 CET Original file -
article xml file uploaded 16 March 2023 10:27 CET Update -
article xml uploaded. 16 March 2023 10:27 CET Update https://www.mdpi.com/1718-7729/30/3/246/xml
article pdf uploaded. 16 March 2023 10:27 CET Updated version of record https://www.mdpi.com/1718-7729/30/3/246/pdf
article html file updated 16 March 2023 10:28 CET Update -
article html file updated 20 March 2023 22:30 CET Update https://www.mdpi.com/1718-7729/30/3/246/html
Back to TopTop